Corporate News Details

Lord’s Mark Industries projects Rs 2000 crore revenue by 2028, prioritizing healthcare expansion

(21-Aug-26   20:53)

Lord’s Mark Industries Limited anticipates total revenue exceeding Rs 2000 crore by fiscal year 2028, targeting a Profit After Tax of 10-11%, according to a recent investor conference call. The company’s Q1 revenue was split with 55% attributed to its In Vitro Diagnostics (IVD) and MedTech segments, and 45% from Renewable Energy, which currently holds an order book of approximately Rs 3000 crore. Management highlighted a strategic focus on the healthcare/MedTech segment, driven by its proprietary technologies and higher margins, while also continuing to develop and acquire technologies like a recent breast cancer testing technology from C-MET. Lord’s Mark is exploring options to enter the hospital business, including developing a new facility or acquiring and converting an existing one, with a potential launch by March 2027, and is actively pursuing inclusion of preventive healthcare products in the Ayushman Bharat scheme.